The Public uses of the past as a source for the study of the thalidomide disaster in Spain
DOI:
https://doi.org/10.11606/khronos.v0i7.159504Keywords:
Thalidomide, Spain, AVITE, Repair, Uses of the past, HistoryAbstract
The teratogeny caused by thalidomide in infants is considered by science to be one of the great pharmaceutical disasters of the twentieth century. Manufactured by a German company, the Grünenthal, the drug was marketed in over 40 countries from the late 1950s, affecting thousands of children. In Spain, thalidomide occupies media space to this day, mainly due to the actions of the Association of Victims of Thalidomide in Spain (AVITE). AVITE, in seeking redress for the victims, acts in indifferent instances. In this article we will analyze some of the tools publicly used by the association, trying to demonstrate how they are triggered in the struggle for justice for those affected.
Downloads
Downloads
Published
Issue
Section
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License in the "Attribution-NonCommercial 4.0 International" (CC BY-NC 4.0) modality that allows sharing of the work with acknowledgment of authorship and initial publication in this magazine.
- Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase impact and citation of the published work (See The Effect of Open Access).
- Any doubts or complaints about copyright must be directed to the Editorial Board or qualify and express themselves in accordance with the guidelines of the Committee on Publications Ethics (COPE).
